Ulster 2005 Conference
A selection of the main presentations

Session 1: Prescribing Quality Indicators

A tool for quality improvement or for the macdonaldization of pharmaceutical policy

Keynote session (chairs: Ingrid Schubert, Alison Bourke)

• Bjorn Wettermark, Bengt Jacobsson, SE
  Quality indicators in policymaking: how can we evaluate the benefits and the adverse events?
• Alison Bourke, UK
  Quality indicators in feedback to prescribers; putting theory into practice and looking at results
• Flora M Haaijer-Ruskamp, NL
  A research agenda for Drug Utilisation Research in quality indicators, outline of collaborative EURODURG research program
  

Session 2: Drug information centres and drug utilization research.

Bringing together medicines information services, evidence-based medicine centres and pharmacovigilance systems

Keynote session (chair: John Feely)

• NHS Information Authority, TBD, UK
  Drug dictionaries and clinical terminology for health information technology systems
• Mary Teeling, National Medicines Information Centre, IE
  Integrating drug information centers and pharmaco-economics
• Robert Vander Stichele, BE
  The interaction between drug utilization research and clinical pharmacy and pharmacology
  

Session 3: Compliance

Patient compliance, adherence and concordance: how able and willing are doctors, pharmacists and nurses to involve patients in treatment decisions and management

Keynote session (chair: Robert Vander Stichele)

• Nicky Britten, UK
  Concordance and taking into account patient perspective in prescribing decisions
• Bernard Vrijens, NL
  Insights from electronic compliance monitoring in patient behavior
• Anders Ekedahl, SE
  Primary non compliance: not redeeming prescriptions in the pharmacy: a sign of mismatch of perceptions?
  

Session 4: Antibiotics

Reducing the threat of antibiotic resistance by improving drug utilisation in hospitals and the community

Keynote session (chairs: Peter Mol, Hugh Webb)

• Peter Davey, UK
  Interventions that work in Hospitals
• Samuel Coenen, BE
  Improving Antibiotic Use in the Community: the Belgian Experience
• Hugh Webb, UK
  Resistance, use & interventions

In addition two presentations are available from the workshop ‘Use = or ≠  Resistance’

• Dominique Monnet: Does Resistance disappear after ceasing inappropriate use?
• Svetlana Ratchina: Public role in the spread of antimicrobial resistance

Session 5: Nonphysician prescribing

Keynote session (chairs: Steve Chapman, Trudy Granby)

• Sue Latter, UK
  The evaluation of independent nurse prescribing in the UK
• Bharat Patel, UK
  Experience of pharmacist supplementary prescribing
• John Blenkinsopp, UK
  The implications of the shift from prescribing to OTC use of chronic medications

Session 6: Prescribing for older people, children and in pregnancy

Safety of psychotropic medication

Keynote session (chair: Lolkje Van Den Bergh)

• Peter Passmore, IE
  Psychotropic medication for older people
• Lolkje TW de Jongh-van den Bergh, NL
  Safety of psychotropic medication in pregnancy: scientific issues
• Emilio Sanz, ES
  Psychotropic medication in children

Session 7: Prescription and morbidity registration

Implications for quality development and pharmacoepidemiological research

Keynote session (chairs: Morten Andersen, Dave Roberts)

• Dave Roberts (UK)
  QMAS - Comprehensive collection of quality of care data from GPs
• David J. Williams (UK)
  Use of prescribing and morbidity data from primary care in pharmacoepidemiologic studies
• Tracey Boyce (UK)
  The Northern Ireland Medicines Governance Team - Improving medication related patient safety